Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes

Molecular Vision

Volumn 18, Issue , 2012, Pages 2749-2757

  Paine, Suman Kalyan ^a   Basu, Analabha ^b   Mondal, Lakshmi Kanta ^c   Sen, Aditi ^a   Choudhuri, Subhadip ^a   Chowdhury, Imran Hussain ^a   Saha, Avijit ^a   Bhadhuri, Gautam ^a   Mukherjee, Ankur ^b   Bhattacharya, Basudev ^a  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b NATIONAL INSTITUTE OF BIOMEDICAL GENOMICS   (India)

^c Regional Institute of Ophthalmology   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; GENE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; IFN GAMMA GENE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINA NEOVASCULARIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; TGF BETA1 GENE; VEGF GENE;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RETINA; RETINAL NEOVASCULARIZATION; SEQUENCE ANALYSIS, DNA; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84870460401     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Abu EA, Ahmed M. Al-Mezaine, Hani S, Ola MS. Pathophysiology and management of diabetic ratinopathy Expert Rev Ophthalmol 2009; 4:627-47.
2. Khan ZA, Chakrabarti S. Growth factors in proliferative diabetic retinopathy. Exp Diabesity Res 2003; 4:287-301. [PMID: 14668050].
3. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102:527-32.[PMID: 6367725].
4. Linsenmeier RA, Braun RD, McRipley MA, Padnick LB, Ahmed J, Hatchell DL, McLeod DS, Lutty GA. Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci 1998; 39:1647-57. [PMID: 9699554].
5. Zhang W, Ito Y, Berlin E, Roberts R, Berkowitz BA. Role of hypoxia during normal retinal vessel development and in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 2003; 44:3119-23. [PMID: 12824260].
6. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 2001; 42:2408-13. [PMID: 11527957].
7. Van Geest RJ, Klaassen I, Vogels IM, Van Noorden CJ, Schlingemann RO. Differential TGF-{beta} signaling in retinal vascular cells: a role in diabetic retinopathy? Invest Ophthalmol Vis Sci 2010; 51:1857-65. [PMID: 19959647].
8. Nagineni CN, Samuel W, Nagineni S, Pardhasaradhi K, Wiggert B, Detrick B, Hooks JJ. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases. J Cell Physiol 2003; 197:453-62. [PMID: 14566975].
9. Organization WH. World Health Organization: definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF Consultation: Diagnosis and Classification of Diabetes Mellitus. Geneva; 2006.
10. Viswanathan V, Tilak P, Kumpatla S. Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: A 12 years observational study. Indian J Med Res 2012; 136:46-53. [PMID: 22885263].
11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215-[PMID: 3344216].
12. Knight JC, McGuire W, Kortok MM, Kwiatkowski D. Accuracy of genotyping of single-nucleotide polymorphisms by PCR-ELISA allele-specific oligonucleotide hybridization typing and by amplification refractory mutation system. Clin Chem 1999; 45:1860-3. [PMID: 10508136].
13. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol 1999; 7:127-8. [PMID: 10544444].
14. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 2005; 76:887-93. [PMID: 15789306].
15. Patz A. Retinal neovascularisation: early contributions of Professor Michaelson and recent observations. Br J Ophthalmol 1984; 68:42-6. [PMID: 6197084].
16. Witmer AN, Blaauwgeers HG, Weich HA, Alitalo K, Vrensen GF, Schlingemann RO. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest Ophthalmol Vis Sci 2002; 43:849-57. [PMID: 11867607].
17. Ishida S, Shinoda K, Kawashima S, Oguchi Y, Okada Y, Ikeda E. Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 2000; 41:1649-56. [PMID: 10845581].
18. Errera FI, Canani LH, Silva ME, Yeh E, Takahashi W, Santos KG, Souto KE, Tschiedel B, Roisenberg I, Gross JL, Passos-Bueno MR. Functional vascular endothelial growth factor -634G>C SNP is associated with proliferative diabetic retinopathy: a case-control study in a Brazilian population of European ancestry. Diabetes Care 2007; 30:275-9. [PMID: 17259494].
19. Valiatti FB, Crispim D, Benfica C, Valiatti BB, Kramer CK, Canani LH. The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy. Arq Bras Endocrinol Metabol 2011; 55:106-13. [PMID: 21584427].
20. Churchill AJ, Carter JG, Ramsden C, Turner SJ, Yeung A, Brenchley PE, Ray DW. VEGF polymorphisms are associated with severity of diabetic retinopathy. Invest Ophthalmol Vis Sci 2008; 49:3611-6. [PMID: 18441306].
21. Xu B, Feng NH, Tong N, Wang ZD, Zhang W, Wu HF, Hua LX. VEGF -460C>T polymorphism and cancer risk: a meta-analysis. Med Oncol 2010; 27:1031-6. [PMID: 19816815].
22. Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P. Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004; 53:861-4. [PMID: 14988276].
23. Nagineni CN, Cherukuri KS, Kutty V, Detrick B, Hooks JJ. Interferon-gamma differentially regulates TGF-beta1 and TGF-beta2 expression in human retinal pigment epithelial cells through JAK-STAT pathway. J Cell Physiol 2007; 210:192-200. [PMID: 17013806].
24. Praidou A, Androudi S, Brazitikos P, Karakiulakis G, Papakonstantinou E, Dimitrakos S. Angiogenic growth factors and their inhibitors in diabetic retinopathy. Curr Diabetes Rev 2010; 6:304-12. [PMID: 20594164].
25. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999; 8:93-7. [PMID: 9887336].
26. van Dijk RA, Engels CC, Schaapherder AF, Mulder-Stapel A, Ten Dijke P, Hamming JF, Lindeman JH. Visualizing TGF-beta and BMP signaling in human atherosclerosis: a histological evaluation based on Smad activation. Histol Histopathol 2012; 27:387-96. [PMID: 22237716].
27. Zorena K, Myśliwska J, Myśliwiec M, Balcerska A, Hak Ł, Lipowski P, Raczyńska K. Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children. Mediators Inflamm 2007; 2007:92196-[PMID: 17641733].
28. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987; 329:630-2. [PMID: 2443857].
29. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P, Malaise M, De Groote D, Louis R, Belaiche J. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113:401-6. [PMID: 9737669].
30. Paine SK, Sen A, Choudhuri S, Mondal LK, Chowdhury IH, Basu A, Mukherjee A, Bhattacharya B. Association of tumor necrosis factor alpha, interleukin 6, and interleukin 10 promoter polymorphism with proliferative diabetic retinopathy in type 2 diabetic subjects. Retina 2012; 32:1197-203. [PMID: 22105495].
31. Goldsby RA, Kindt TJ, Osborne BA. Leukocyte migration and inflammation. Kuby Immunology. 2001; 4:388-91.
32. Liu B, Faia L, Hu M, Nussenblatt RB. Pro-angiogenic effect of IFN gamma is dependent on the PI3K/mTOR/translational pathway in human retinal pigmented epithelial cells. Mol Vis 2010; 16:184-93. [PMID: 20157617].
33. Dace DS, Khan AA, Kelly J, Apte RS. Interleukin-10 promotes pathological angiogenesis by regulating macrophage response to hypoxia during development. PLoS ONE 2008; 3:e3381-[PMID: 18852882].
34. Chavira-Suárez E, Sandoval A, Quintero H, Bustamante P, Felix R, Lamas M. Hyperglycemia induces early upregulation of the calcium sensor KChIP3/DREAM/calsenilin in the rat retina. Biochem Biophys Res Commun 2012; 418:420-5. [PMID: 22277672].